Human cervical carcinomas and EGF-R tyrosine kinase inhibitors.
Al Moustafa
Ala-Eddin
AE
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D011799:Quinazolines / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D004791:Enzyme Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib